The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, J.
Right arrow Articles by Drew, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, J.
Right arrow Articles by Drew, P. D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2007, 178: 1904-1913.
Copyright © 2007 by The American Association of Immunologists, Inc.

Peroxisome Proliferator-Activated Receptor-{gamma} Agonists Suppress the Production of IL-12 Family Cytokines by Activated Glia1

Jihong Xu and Paul D. Drew2

Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, AR 72205

The IL-12 family of cytokines, which include IL-12, IL-23, and IL-27, play critical roles in the differentiation of Th1 cells and are believed to contribute to the development of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), an animal model of MS. Relatively little is known concerning the expression of IL-12 family cytokines by cells of the CNS, the affected tissue in MS. Previously, we and others demonstrated that peroxisome proliferator-activated receptor (PPAR)-{gamma} agonists suppress the development of EAE, alter T cell proliferation and phenotype, and suppress the activation of APCs. The present studies demonstrated that PPAR-{gamma} agonists, including the naturally occurring 15-deoxy-{Delta}12,14-PGJ2 and the synthetic thiazoladinedione rosiglitazone, inhibited the induction of IL-12p40, IL-12p70 (p35/p40), IL-23 (p19/p40), and IL-27p28 proteins by LPS-stimulated primary microglia. In primary astrocytes, LPS induced the production of IL-12p40, IL-23, and IL-27p28 proteins. However, IL-12p70 production was not detected in these cells. The 15-deoxy-{Delta}12,14-PGJ2 potently suppressed IL-12p40, IL-23, and IL-27p28 production by primary astrocytes, whereas rosiglitazone suppressed IL-23 and IL-27p28, but not IL-12p40 in these cells. These novel observations suggest that PPAR-{gamma} agonists modulate the development of EAE, at least in part, by inhibiting the production of IL-12 family cytokines by CNS glia. In addition, we demonstrate that PPAR-{gamma} agonists inhibit TLR2, MyD88, and CD14 expression in glia, suggesting a possible mechanism by which these agonists modulate IL-12 family cytokine expression. Collectively, these studies suggest that PPAR-{gamma} agonists may be beneficial in the treatment of MS.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the National Institutes of Health (NS42860 and NS 047546), the National Multiple Sclerosis Society (RG 3427-A-8), and the Arkansas Biosciences Institute.

2 Address correspondence and reprint requests to Dr. Paul D. Drew, University of Arkansas for Medical Sciences, Department of Neurobiology and Developmental Sciences, Slot 846, Biomedical Research Building II, Room 563-2, 4301 West Markham Street, Little Rock, AR 72205. E-mail address: drewpauld{at}uams.edu

3 Abbreviations used in this paper: MS, multiple sclerosis; 15d-PGJ2, 15-deoxy-{Delta}12,14-PGJ2; EAE, experimental autoimmune encephalomyelitis; EBI3, EBV-induced molecule 3; PAMP, pathogen-associated molecular pattern; PPAR, peroxisome proliferator-activated receptor.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
S. Kempe, P. Heinz, E. Kokai, O. Devergne, N. Marx, and T. Wirth
Epstein-Barr Virus-Induced Gene-3 Is Expressed in Human Atheroma Plaques
Am. J. Pathol., July 1, 2009; 175(1): 440 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. R. Tambuyzer, P. Ponsaerts, and E. J. Nouwen
Microglia: gatekeepers of central nervous system immunology
J. Leukoc. Biol., March 1, 2009; 85(3): 352 - 370.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. K. Phulwani, N. Esen, M. Md. Syed, and T. Kielian
TLR2 Expression in Astrocytes Is Induced by TNF-{alpha}- and NF-{kappa}B-Dependent Pathways
J. Immunol., September 15, 2008; 181(6): 3841 - 3849.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kielian, M. Md. Syed, S. Liu, N. K. Phulwani, N. Phillips, G. Wagoner, P. D. Drew, and N. Esen
The Synthetic Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Ciglitazone Attenuates Neuroinflammation and Accelerates Encapsulation in Bacterial Brain Abscesses
J. Immunol., April 1, 2008; 180(7): 5004 - 5016.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.